OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)--OlivePoint Capital (“OlivePoint”), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative investment manager focused on opportunistic credit and other special situation investments (“Redwood Capital”), today announced its acquisition of 3900 Paramount Parkway, a 220,000-square-foot Class A office building located within Research Triangle Park (RTP) in Raleigh–Durham, one of the fastest-growing innovation hubs in the United States.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215054691/en/3900 Paramount Parkway - Raleigh, NCThe property is 100% leased to Pharmaceutical Product Development (PPD), a subsidiary of Thermo Fisher Scientific (NYSE: TMO) - a global leader in life sciences with an A– S&P credit rating - and benefits from a long lease duration and full corporate credit suppor
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- US In Vitro Diagnostics Market worth $57.18 Billion by 2031 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific (NYSE:TMO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- 3 Profitable Stocks Walking a Fine Line [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 10/22/25 - Beat
TMO
Sec Filings
- 12/11/25 - Form 4
- 12/8/25 - Form CERT
- 12/8/25 - Form CERT
- TMO's page on the SEC website